53 evolution "https:" "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at Fred Hutchinson Cancer Center
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
and phenotypes through bioinformatics, data science, genomics, spatial biology, and drug development are encouraged to apply. Responsibilities The research projects and responsibilities for this Staff
-
, innovation, integrity, and respect. Responsibilities PRIMARY/ESSENTIAL DUTIES: Execute error-corrected NGS assay development and validation experiments in the laboratory. Document all work in electronic
-
website for further information. The Singhvi Lab provides a supportive environment that strongly emphasizes individualized mentoring. Upon joining, we will prioritize your continued development as an
-
PK processing documents. Research Development: Establish and maintain positive, collaborative working relationships with faculty, research staff, and clinic operations to help ensure services and user
-
findings. Other duties as assigned. Qualifications Required: Bachelor's degree or equivalent combination of education and experience. Minimum 1 year of experience working with data (data development
-
and require independent decision-making, analysis, policy and program development, problem and issue resolution and leadership skills. This role will be full-time, 8am-5pm Monday-Friday, requiring one
-
. The Quality Assurance Associate II is responsible for assisting in the development and monitoring of quality systems that support cellular collection, processing and infusion for the Cellular Therapeutics
-
candidates. Understanding the factors that impact vaccine response and identifying the features of the immune response that confer protection can provide critical feedback for vaccine development. As part of
-
agreements. Develop innovative budgeting strategies, templates, SOPs & training materials to support a complex budget development function Mentor, support, and develop staff, including direct management
-
on improving existing, and developing novel, antibody-based immunotherapies, and rendering them safer for clinical application. Current projects include preclinical drug development/testing (in part with